EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Gut Trimethylamine Cycle: Microbial Ecology, Quantitative Metabolic Flux, and Therapeutic Targeting

Yangyang Zhao, Xin Xing

X-Disciplinarity · 2025

DOI: 10.63174/xdi.hkrh5552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift X-Disciplinarity, 2025. Verfasst von Yangyang Zhao und 1 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trimethylamine (TMA) and its hepatic oxidation product, trimethylamine N-oxide (TMAO), form a pivotal gut–liver metabolic axis linking the intestinal microbiota with host cardiometabolic health. Elevated plasma TMAO levels have been consistently associated with atherosclerosis, chronic kidney disease, diabetes, and other metabolic disorders. This review systematically summarizes current advances in understanding the microbial ecology and biochemical pathways underlying the gut TMA cycle. We highlight three major microbial routes for TMA generation—cutC/D-mediated choline cleavage, cntA/B-dependent carnitine oxidation, and BbuA-associated γ-butyrobetaine reduction - as well as methanogenic and acetogenic pathways responsible for TMA utilization and detoxification. Integrating multi-omics data with metabolic-flux modeling provides quantitative insight into the gut–liver TMA network, revealing key rate-limiting nodes and interindividual variability driven by diet and microbial composition. Emerging intervention strategies include chemical inhibition of cutC/D, cntA/B activity, dietary modulation, probiotic or engineered consortia enhancing TMA clearance, and bacteriophage-based precision targeting of TMA-producing taxa. Finally, we propose developing a gut TMA index and mapping producer–degrader interaction networks as frameworks for personalized risk evaluation and therapeutic design. Collectively, quantitative and translational studies of the TMA cycle are expected to establish new paradigms for microbiome-driven prevention and treatment of cardiometabolic diseases.

Zitieren

APA

Zhao, Y., & Xing, X. (2025). The Gut Trimethylamine Cycle: Microbial Ecology, Quantitative Metabolic Flux, and Therapeutic Targeting. X-Disciplinarity. https://doi.org/10.63174/xdi.hkrh5552

Vancouver

Zhao Y, Xing X. The Gut Trimethylamine Cycle: Microbial Ecology, Quantitative Metabolic Flux, and Therapeutic Targeting. X-Disciplinarity. 2025. doi:10.63174/xdi.hkrh5552

BibTeX
@article{Zhao2025,
  author = {Zhao, Yangyang and Xing, Xin},
  title = {The Gut Trimethylamine Cycle: Microbial Ecology, Quantitative Metabolic Flux, and Therapeutic Targeting},
  journal = {X-Disciplinarity},
  year = {2025},
  doi = {10.63174/xdi.hkrh5552}
}
Kostenlos starten →